OTC : TWAPF

Towa Pharmaceutical Co., Ltd.

$26 USD

$0 (0.0%)

Volume
100
Average Volume
3
Market Capitalization
$1.28B
P/E Ratio
38.58
Dividend Yield
1.94%
Price Target
Year High
$26.00
Year Low
$16.83
Day High
Day Low
Payout Ratio
$0.75
Current Ratio
$2.76
Company Overview

OTC

Itsuro Yoshida

Drug Manufacturers - Specialty & Generic

Healthcare

TWAPF

4923

JP

USD

81 6 6900 9100

N/A

N/A

Liquidity Metrics

1.27

2.76

1.49

0.47

0.75

Sales & Valuation

$275.43B

0.74

1.14

24.85

165.60

Profitability

$107.05

$5.28B

1.92%

4.81%

2.92%

1.10%

P/E Metrics

38.58

-0.53

-0.53

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

2.06

6/9

$171.55B

$478.28B

$299.05B

$26.62B

Key Metrics (TTM)

$384B

1.40

10.04

2.76

2.92%

2.25%

2.59%

4.02%

$2946.42

287 days

Company Executives
Name Title
Masaji Morikawa Operating Officer & Division Manager of Sales and Marketing Division
Osamu Uchikawa Executive MD & Director
Itsuro Yoshida President & Representative Director
Naomichi Hashizume Human Resources Division Chief
Shigeki Fujita Operating Officer & GM of Human Resource Development Center
Takahiko Taniguchi Senior Executive Officer & Head of Quality Assurance Division
Takeshi Sugiura Executive Officer
Shiro Hatagami Operating Officer and GM of Accounting & Finance Division
Masao Tanaka Director
Yutaka Okuda Senior Operating Officer & Div Manager of R&D Div and Unit Manager of Innovative Tech Research
Yasuyuki Oishi Executive Officer
Tetsuo Yamashita Operating Officer, Plant Manager of Okayama Plant & GM of Administration Department
Poll Results

No votes yet today — be the first to share your view!

About Towa Pharmaceutical Co., Ltd. (OTC:TWAPF) Stock

Operating in Japan, Towa Pharmaceutical Co., Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates. The company's extensive portfolio addresses critical therapeutic areas such as diabetes, digestive health, neurological conditions, and allergic diseases, alongside offering vitamins, antibiotics, and oncology treatments. With approximately 700 different drug products, Towa Pharmaceutical Co., Ltd. was established in 1951 and is headquartered in Osaka, Japan. ...

Frequently Asked Questions

What is the current Towa Pharmaceutical Co., Ltd. (TWAPF) stock price?

Towa Pharmaceutical Co., Ltd.(OTC:TWAPF) stock price is $26 in the last trading session. During the trading session, TWAPF stock reached the peak price of $26 while $16.83 was the lowest point it dropped to. The percentage change in TWAPF stock occurred in the recent session was 0.0% while the dollar amount for the price change in TWAPF stock was $0.

TWAPF's industry and sector of operation?

The OTC listed TWAPF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of TWAPF?

Masaji Morikawa | Operating Officer & Division Manager of Sales and Marketing Division
Osamu Uchikawa | Executive MD & Director
Itsuro Yoshida | President & Representative Director
Naomichi Hashizume | Human Resources Division Chief
Shigeki Fujita | Operating Officer & GM of Human Resource Development Center

How many employees does TWAPF have?

Number of TWAPF employees currently stands at 4923. TWAPF operates from 2-11, Shinbashi-cho, Osaka, None 571-8580, JP.

Link for TWAPF official website?

Official Website of TWAPF is: https://www.towayakuhin.co.jp

How do I contact TWAPF?

TWAPF could be contacted at phone #81 6 6900 9100 and can also be accessed through its website. TWAPF operates from 2-11, Shinbashi-cho, Osaka, None 571-8580, JP.

How many shares of TWAPF are traded daily?

The average number of TWAPF shares traded daily for last 3 months was 3.

What is the market cap of TWAPF currently?

The market value of TWAPF currently stands at $1.28B with its latest stock price at $26